LGI1 and encephalitis: Among them, 48 (46.6%) had anti-NMDAR encephalitis, 28 (27.2%) had anti-LGI1 encephalitis, 20 (19.4%) had anti-GABABR encephalitis, and 7 (6.8%) had anti-CASPR2 encephalitis.